Volume 23 (2020)
Volume 22 (2019)
Volume 21 (2018)
Volume 20 (2017)
Volume 19 (2016)
Volume 18 (2015)
Volume 17 (2014)
Volume 16 (2013)
Volume 15 (2012)
Volume 14 (2011)
Volume 13 (2010)
Volume 12 (2009)
Volume 11 (2008)
Volume 10 (2007)
Volume 9 (2006)
Volume 8 (2005)
Volume 7 (2004)
Volume 6 (2002)
Volume 5 (2002)
Volume 4 (2000)
Volume 3 (1999)
Volume 2 (1998)
Volume 1 (1997)
1. Specific cutaneous manifestations in adult T cell leukemia/lymphoma

FZ Pezeshk Poor; MJ Yazdan Panah; A Shir Del

Volume 9, Issue 3 , 2006, , Pages 227-232

Abstract
  Background and aim: Adult T cell leukemia/lymphoma (ATLL) is an aggresive malignancy which may occur in human T lymphotropic virus1(HTLV1) infected persons. HTLV1 is endemic in Khorasan with prevalence of 2.3% in general population. Since specific cutaneous manifestations of lymphoma may occur in a significant ...  Read More

4. Survey of cutaneous complications after renal transplantation in Emam Reza and Qaem hospitals, Mashhad

MJ Yazdan Panah; M Ebrahimi Rad; MJ Mojahedi

Volume 8, Issue 4 , 2005, , Pages 281-286

Abstract
  Background and objective: Renal transplantation is an appropriate treatment for end stage renal disease and helps prolongation of patients survival with better quality, but immunosuppressive drugs that are used for inhibition of rejection after transplantation may cause some adverse effects in other ...  Read More

5. Association of Vitiligo and diabetes mellitus in 750 diabetic patients referred to Mashad Diabetes Center in Shahrivar 1380

F Pezeshk Pour; MJ Yazdan Panah; AR Taheri; H Assadi

Volume 6, Issue 4 , 2003, , Pages 28-30

Abstract
  Background: Vitiligo is a common autoimmune skin disease that may occur in association with other autoimmune disorders especially those of the endocrine system. Diabetes mellitus is a common endocrine disease associated with vitiligo. Objective: To study the association of vitiligo and diabetes mellitus. ...  Read More

6. Oral Zinc Sulfate in the treatment of acute cutaneous Leishmaniasis

MJ Yazdan Panah; SK Mostoufi; M Soleimani

Volume 6, Issue 2 , 2003, , Pages 20-24

Abstract
  Background: Different local and systemic modalities are suggested in the treatment of cutaneous leishmaniasis (CL), but the pentavalent antimony compounds are still considered as the first line of treatment. Regarding to increase in clinical drug resistance, adverse effects and low compliance of patient, ...  Read More